Dr. Natasha Sheybani is an Assistant Professor of Biomedical Engineering at the University of Virginia and Research Director of UVA’s Focused Ultrasound Cancer Immunotherapy Center. She directs a multidisciplinary, translational research program leveraging focused ultrasound and image-guided theranostics to develop precision immunotherapy, cell therapy, and gene therapy strategies for cancer treatment. Her work closely integrates with multiple clinical investigations of focused ultrasound in oncology at UVA. Dr. Sheybani earned her B.S. in Biomedical Engineering (with Honors) from Virginia Commonwealth University, her Ph.D. in Biomedical Engineering from UVA, and completed postdoctoral training in Oncology, Biomedical Data Science, and Radiology at Stanford University. She has been recognized with numerous prestigious awards, including the NSF Graduate Research Fellowship, the NCI F99/K00 Predoctoral-to-Postdoctoral Transition Award, the NIH Director’s Early Independence Award, and the DoD Breast Cancer Research Program Era of Hope Scholar Award. Her research and leadership have garnered international recognition, including selection to STAT News’ “Wunderkinds” and Forbes’ “30 Under 30” in Science. She currently serves as Treasurer of the International Society for Therapeutic Ultrasound, Co-Chair of the Academy for Radiology & Biomedical Imaging Research Council of Early Career Investigators in Imaging, and as a scientific advisor to the National Brain Tumor Society.